Modelling psychiatric disorders in animals has been hindered by several challenges related to our poor understanding of the disease causes. This chapter describes recent advances in translational research which may lead to animal models and relevant proteomic biomarkers that can be informative about disease mechanisms and potential new therapeutic targets. The review focuses on the behavioural and molecular correlates in models of schizophrenia and major depressive disorder, as guided by recently established Research Domain Criteria (RDoC). This approach is based on providing proteomic data for aetiologically driven, behaviourally well-characterised animal models to link discovered biomarker candidates with the human disease.
CITATION STYLE
Sarnyai, Z., & Guest, P. C. (2017). Connecting brain proteomics with behavioural neuroscience in translational animal models of neuropsychiatric disorders. In Advances in Experimental Medicine and Biology (Vol. 974, pp. 97–114). Springer New York LLC. https://doi.org/10.1007/978-3-319-52479-5_6
Mendeley helps you to discover research relevant for your work.